Nosocomial outbreak of genetically related IMP-1 β-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan

International Journal of Antimicrobial Agents

Volumn 29, Issue 3, 2007, Pages 306-310

  Fukigai, Shinako ^a   Alba, Jimena ^b   Kimura, Soichiro ^b   Iida, Toshie ^a   Nishikura, Noriko ^a   Ishii, Yoshikazu ^b   Yamaguchi, Keizo ^b  

^a Hanyu General Hospital   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

IMP 1; Klebsiella pneumoniae; Metallo lactamase; Nosocomial infection

Indexed keywords

AGAR; AMIKACIN; AZTREONAM; BETA LACTAMASE; CEFTAZIDIME; DIPICOLINIC ACID; IMIPENEM; INOSITOL PHOSPHATE; INTEGRASE; LEVOFLOXACIN; METALLO BETA LACTAMASE; MINOCYCLINE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGAR MEDIUM; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; DRUG CONTROL; FEMALE; GENE; GENE CLUSTER; GENERAL HOSPITAL; GENETIC STRAIN; HOSPITAL INFECTION; HUMAN; HYGIENE; JAPAN; KLEBSIELLA PNEUMONIAE; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS;

AGED; AGED, 80 AND OVER; BASE SEQUENCE; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENES, BACTERIAL; HOSPITALS, GENERAL; HUMANS; INTEGRASES; JAPAN; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED;

EID: 33846936549     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.10.011     Document Type: Article

References (26)

1. Podschun R., and Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 11 (1998) 589-603
2. Paterson D.L., Ko W.C., Von Gottberg A., et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Int Med 140 (2004) 26-32
3. Nordmann P., and Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 8 (2002) 321-331
4. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-β-lactamases: the quiet before the storm?. Clin Microbiol Rev 18 (2005) 306-325
5. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264 (1994) 382-388
6. Piddock L.J. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin Microbiol Rev 19 (2006) 382-402
7. Jacoby G.A., and Munoz-Price L.S. The new β-lactamases. N Engl J Med 352 (2005) 380-391
8. Walther-Rasmussen J., and Hoiby N. OXA-type carbapenemases. J Antimicrob Chemother 57 (2006) 373-383
9. Watanabe M., Iyobe S., Inoue M., and Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 35 (1991) 147-151
10. Shibata N., Doi Y., Yamane K., et al. PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol 41 (2003) 5407-5413
11. Koh T.H., Babini G.S., Woodford N., Sng L.H., Hall L.M., and Livermore D.M. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae from Singapore. Lancet 353 (1999) 2162
12. Lincopan N., McCulloch J.A., Reinert C., Cassettari V.C., Gales A.C., and Mamizuka E.M. First isolation of metallo-β-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil. J Clin Microbiol 43 (2005) 516-519
13. IMP-8 in a university medical center in Taiwan. J Clin Microbiol 39 (2001) 4433-4439
14. Giakkoupi P., Xanthaki A., Kanelopoulou M., et al. VIM-1 metallo-β-lactamase-producing Klebsiella pneumoniae strains in Greek hospitals. J Clin Microbiol 41 (2003) 3893-3896
15. Luzzaro F., Docquier J.D., Colinon C., et al. Emergence in Klebsiella pneumoniae and Enterobacter cloacae clinical isolates of the VIM-4 metallo-β-lactamase encoded by a conjugative plasmid. Antimicrob Agents Chemother 48 (2004) 648-650
16. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th ed. Approved standard. M7-A5. Wayne, PA: NCCLS, 2003.
17. Kimura S., Ishii Y., and Yamaguchi K. Evaluation of dipicolinic acid for detection of IMP- or VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis 53 (2005) 241-244
18. Kimura S., Alba J., Shiroto K., et al. Clonal diversity of metallo-beta-lactamase-possessing Pseudomonas aeruginosa in geographically diverse regions of Japan. J Clin Microbiol 43 (2005) 458-461
19. Iyobe S., Kusadokoro H., Ozaki J., et al. Amino acid substitutions in a variant of IMP-1 metallo-β-lactamase. Antimicrob Agents Chemother 44 (2000) 2023-2027
20. Shaw K.J., Cramer C.A., Rizzo M., et al. Isolation, characterization, and DNA sequence analysis of an AAC(6′)-II gene from Pseudomonas aeruginosa. Antimicrob Agents Chemother 33 (1989) 2052-2062
21. VIM-1 metallo-β-lactamase gene. J Clin Microbiol 43 (2005) 5344-5347
22. SHV-5 in a French University hospital. J Antimicrob Chemother 57 (2006) 142-145
23. Yamaguchi K., Ohno A., and Levofloxacin Surveillance Group. Investigation of the susceptibility trends in Japan to fluoroquinolones and other antimicrobial agents in a nationwide collection of clinical isolates: a longitudinal analysis from 1994 to 2002. Diagn Microbiol Infect Dis 52 (2005) 135-143
24. Hoban D.J., Biedenbach D.J., Mutnick A.H., and Jones R.N. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Diagn Microbiol Infect Dis 45 (2003) 279-285
25. Brahmi N., Blel Y., Kouraichi N., et al. Impact of ceftazidime restriction on gram-negative bacterial resistance in an intensive care unit. J Infect Chemother 12 (2006) 190-194
26. Girouard S., Levine G., Goodrich K., et al. Infection control programs at children's hospitals: a description of structures and processes. Am J Infect Control 29 (2001) 145-151